| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13778* | 2021 |
| Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis VA Brown, KR Patel, M Viskaduraki, JA Crowell, M Perloff, TD Booth, ... Cancer research 70 (22), 9003-9011, 2010 | 734 | 2010 |
| Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients KR Patel, VA Brown, DJL Jones, RG Britton, D Hemingway, AS Miller, ... Cancer research 70 (19), 7392-7399, 2010 | 684 | 2010 |
| Clinical trials of resveratrol KR Patel, E Scott, VA Brown, AJ Gescher, WP Steward, K Brown Annals of the New York Academy of Sciences 1215 (1), 161-169, 2011 | 606 | 2011 |
| What is new for an old molecule? Systematic review and recommendations on the use of resveratrol O Vang, N Ahmad, CA Baile, JA Baur, K Brown, A Csiszar, DK Das, ... PloS one 6 (6), e19881, 2011 | 550 | 2011 |
| Cancer chemoprevention: a rapidly evolving field WP Steward, K Brown British journal of cancer 109 (1), 1-7, 2013 | 477 | 2013 |
| Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—Safety, pharmacokinetics, and pharmacodynamics LM Howells, DP Berry, PJ Elliott, EW Jacobson, E Hoffmann, B Hegarty, ... Cancer prevention research 4 (9), 1419-1425, 2011 | 457 | 2011 |
| Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence KR Patel, C Andreadi, RG Britton, E Horner-Glister, A Karmokar, S Sale, ... Science translational medicine 5 (205), 205ra133-205ra133, 2013 | 231 | 2013 |
| Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial LM Howells, COO Iwuji, GRB Irving, S Barber, H Walter, Z Sidat, ... The Journal of nutrition 149 (7), 1133-1139, 2019 | 211 | 2019 |
| Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy MI James, C Iwuji, G Irving, A Karmokar, JA Higgins, N Griffin-Teal, ... Cancer letters 364 (2), 135-141, 2015 | 200 | 2015 |
| Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice H Cai, E Scott, A Kholghi, C Andreadi, A Rufini, A Karmokar, RG Britton, ... Science translational medicine 7 (298), 298ra117-298ra117, 2015 | 193 | 2015 |
| Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people S Ling, K Brown, JK Miksza, L Howells, A Morrison, E Issa, T Yates, ... Diabetes care 43 (9), 2313-2322, 2020 | 188 | 2020 |
| Pilot study of oral anthocyanins for colorectal cancer chemoprevention S Thomasset, DP Berry, H Cai, K West, TH Marczylo, D Marsden, K Brown, ... Cancer prevention research 2 (7), 625-633, 2009 | 153 | 2009 |
| Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms RG Britton, C Kovoor, K Brown Annals of the New York Academy of Sciences 1348 (1), 124-133, 2015 | 144 | 2015 |
| Resveratrol in human cancer chemoprevention–choosing the ‘right’dose E Scott, WP Steward, AJ Gescher, K Brown Molecular nutrition & food research 56 (1), 7-13, 2012 | 135 | 2012 |
| Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration—a clinical pilot study including assessment of patient acceptability GRB Irving, LM Howells, S Sale, I Kralj-Hans, WS Atkin, SK Clark, ... Cancer prevention research 6 (2), 119-128, 2013 | 134 | 2013 |
| Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA DJ Boocock, K Brown, AH Gibbs, E Sanchez, KW Turteltaub, INH White Carcinogenesis 23 (11), 1897-1902, 2002 | 133 | 2002 |
| Curcumin: the potential for efficacy in gastrointestinal diseases GRB Irving, A Karmokar, DP Berry, K Brown, WP Steward Best practice & research Clinical gastroenterology 25 (4-5), 519-534, 2011 | 127 | 2011 |
| Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice TH Marczylo, D Cooke, K Brown, WP Steward, AJ Gescher Cancer Chemotherapy and Pharmacology 64, 1261-1268, 2009 | 127 | 2009 |
| DNA adducts: mass spectrometry methods and future prospects PB Farmer, K Brown, E Tompkins, VL Emms, DJL Jones, R Singh, ... Toxicology and applied pharmacology 207 (2), 293-301, 2005 | 120 | 2005 |
